Literature DB >> 15607938

The role of proteoglycans in Schwann cell/astrocyte interactions and in regeneration failure at PNS/CNS interfaces.

Barbara Grimpe1, Yelena Pressman, Michael David Lupa, Kevin Paul Horn, Mary Bartlett Bunge, Jerry Silver.   

Abstract

In the dorsal root entry zone (DREZ) peripheral sensory axons fail to regenerate past the peripheral nervous system/central nervous system (PNS/CNS) interface. Additionally, in the spinal cord, central fibers that regenerate into Schwann cell (SC) bridges can enter but do not exit at the distal Schwann cell/astrocyte (AC) boundary. At both interfaces where limited mixing of the two cell types occurs, one can observe an up-regulation of inhibitory chondroitin sulfate proteoglycans (CSPGs). We treated confrontation Schwann cell/astrocyte cultures with the following: (1) a deoxyribonucleic acid (DNA) enzyme against the glycosaminoglycan (GAG)-chain-initiating enzyme, xylosyltransferase-1 (XT-1), (2) a control DNA enzyme, and (3) chondroitinase ABC (Ch'ase ABC) to degrade the GAG chains. Both techniques for reducing CSPGs allowed Schwann cells to penetrate deeply into the territory of the astrocytes. After adding sensory neurons to the assay, the axons showed different growth behaviors depending upon the glial cell type that they first encountered during regeneration. Our results help to explain why regeneration fails at PNS/CNS glial boundaries.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15607938     DOI: 10.1016/j.mcn.2004.06.010

Source DB:  PubMed          Journal:  Mol Cell Neurosci        ISSN: 1044-7431            Impact factor:   4.314


  36 in total

1.  Astrocyte-produced ephrins inhibit schwann cell migration via VAV2 signaling.

Authors:  Fardad T Afshari; Jessica C Kwok; James W Fawcett
Journal:  J Neurosci       Date:  2010-03-24       Impact factor: 6.167

2.  Chronic enhancement of the intrinsic growth capacity of sensory neurons combined with the degradation of inhibitory proteoglycans allows functional regeneration of sensory axons through the dorsal root entry zone in the mammalian spinal cord.

Authors:  Michael P Steinmetz; Kevin P Horn; Veronica J Tom; Jared H Miller; Sarah A Busch; Dileep Nair; Daniel J Silver; Jerry Silver
Journal:  J Neurosci       Date:  2005-08-31       Impact factor: 6.167

Review 3.  Combination treatment with chondroitinase ABC in spinal cord injury--breaking the barrier.

Authors:  Rong-Rong Zhao; James W Fawcett
Journal:  Neurosci Bull       Date:  2013-07-09       Impact factor: 5.203

4.  Kallikrein cascades in traumatic spinal cord injury: in vitro evidence for roles in axonopathy and neuron degeneration.

Authors:  Maja Radulovic; Hyesook Yoon; Nadya Larson; Jianmin Wu; Rachel Linbo; Joshua E Burda; Eleftherios P Diamandis; Sachiko I Blaber; Michael Blaber; Michael G Fehlings; Isobel A Scarisbrick
Journal:  J Neuropathol Exp Neurol       Date:  2013-11       Impact factor: 3.685

5.  Nerve regeneration restores supraspinal control of bladder function after complete spinal cord injury.

Authors:  Yu-Shang Lee; Ching-Yi Lin; Hai-Hong Jiang; Marc Depaul; Vernon W Lin; Jerry Silver
Journal:  J Neurosci       Date:  2013-06-26       Impact factor: 6.167

Review 6.  Contributions of chondroitin sulfate proteoglycans to neurodevelopment, injury, and cancer.

Authors:  Daniel J Silver; Jerry Silver
Journal:  Curr Opin Neurobiol       Date:  2014-04-22       Impact factor: 6.627

7.  Analysis of Schwann-astrocyte interactions using in vitro assays.

Authors:  Fardad T Afshari; Jessica C Kwok; James W Fawcett
Journal:  J Vis Exp       Date:  2011-01-13       Impact factor: 1.355

8.  GDNF modifies reactive astrogliosis allowing robust axonal regeneration through Schwann cell-seeded guidance channels after spinal cord injury.

Authors:  Ling-Xiao Deng; Jianguo Hu; Naikui Liu; Xiaofei Wang; George M Smith; Xuejun Wen; Xiao-Ming Xu
Journal:  Exp Neurol       Date:  2011-02-21       Impact factor: 5.330

9.  A novel biological function for CD44 in axon growth of retinal ganglion cells identified by a bioinformatics approach.

Authors:  Albert Ries; Jeffrey L Goldberg; Barbara Grimpe
Journal:  J Neurochem       Date:  2007-08-30       Impact factor: 5.372

10.  Modulating Sema3A signal with a L1 mimetic peptide is not sufficient to promote motor recovery and axon regeneration after spinal cord injury.

Authors:  Erik Mire; Nicole Thomasset; Lyn B Jakeman; Geneviève Rougon
Journal:  Mol Cell Neurosci       Date:  2007-10-03       Impact factor: 4.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.